Garmin Stock Price, News & Analysis

Garmin (NYSE: GRMN) was named Most Innovative Marine Company (EPIC Awards) for 2025 by Soundings Trade Only on Oct. 8, 2025, marking the third consecutive year Garmin has won the top honor and its eighth consecutive year among the Top 5.

The company also won the Work Culture category for employee well-being and innovative workplace practices, and for the 11th consecutive year was named Manufacturer of the Year by NMEA. Judges cited Garmin's technology, products, workforce initiatives and leadership.

Garmin (NYSE: GRMN) has announced its upcoming third quarter 2025 earnings conference call, scheduled for Wednesday, October 29, 2025, at 10:30 a.m. EDT. The company will release its earnings report before the market opens on the same day.

Investors and shareholders can access the live webcast through Garmin's investor relations website. U.S. and Canadian participants and analysts who wish to participate in the Q&A session can dial 1.888.500.3691. The webcast archive will remain available until October 28, 2026.

Garmin (NYSE: GRMN) has launched the new eTrex Touch GPS handheld navigator, featuring a high-resolution 3-inch color touchscreen and preloaded TopoActive maps. The device offers exceptional battery life of up to 130 hours in standard mode and 650 hours in expedition mode.

The rugged navigator includes multi-band GPS support for superior location accuracy, IP67 dust/water rating, and MIL-STD-810 impact resistance. Priced at $449.99, the device comes with preloaded TopoActive maps and offers optional Outdoor Maps+ subscription for premium mapping content. Users can connect with the Garmin Explore™ smartphone app for trip planning and route management.

Garmin (NYSE: GRMN) has been named Manufacturer of the Year by the National Marine Electronics Association (NMEA) for the 11th consecutive year. The company also secured eight Product of Excellence awards across various marine electronics categories at the annual NMEA conference in West Palm Beach, Florida.

The awards span multiple categories including multi-function display, fishfinder, autopilot, multimedia entertainment, AIS, marine safety device, satellite communication antenna, and marine specialty product. Notable achievements include Garmin's 11th consecutive win in the MFD category and 13th consecutive honor in the autopilot category. The company has now accumulated a total of 72 NMEA honors for excellence across marine product, service, and support categories.

Garmin (NYSE: GRMN) has launched the Descent X30, a new eco-friendly dive computer featuring a large 2.4-inch display. The device, priced at $749.99, is constructed with recycled ocean-bound plastics and offers up to 30 hours of battery life.

Key features include leakproof metal buttons, 10 ATM dive rating, NDL Aware depth metrics, surface GPS navigation, and a 3-axis digital compass. The device supports multiple dive profiles, including trimix, and can be paired with an inReach satellite communicator for SOS messaging capabilities.

Garmin (NYSE:GRMN) has announced a strategic partnership with golf strategy app Noonan to integrate launch monitor data into Noonan's digital caddie platform. The integration leverages the Garmin Golf Premium API to allow users to import their practice data directly into Noonan's platform.

The collaboration enables Noonan to become the first app to utilize Garmin launch monitor data for real-time club and aim recommendations. Powered by Scattershot AI™, the system analyzes various club-and-aim combinations to calculate success probabilities and minimize risks. The integration specifically works with Garmin Approach® R10 and Approach® R50 launch monitors, focusing on crucial metrics like carry distance and offline dispersion.

Garmin (NYSE: GRMN) hosted its annual Garmin Health Summit at the New York Stock Exchange, showcasing digital health innovations and announcing key developments. The event featured the 2025 Garmin Health Awards, with Fimo Health winning Expert's Choice for their cancer-related fatigue monitoring solution, and Optimity securing People's Choice for their behavioral health platform.

The summit included major announcements: the launch of the Venu 4 smartwatch, a strategic partnership with King's College for maternal health research (EMBRACE project), and insights from Harvard and Oxford's Health and Happiness Study. Dr. Arjun Athreya from Mayo Clinic delivered a keynote on a 12-month decentralized study using Garmin smartwatches, while experts from various institutions shared insights on wearable technology applications in healthcare, insurance, and fitness sectors.

Garmin (NYSE: GRMN) has announced a strategic collaboration with Meta to integrate real-time fitness data into Oakley Meta Vanguard AI glasses. The partnership enables athletes using compatible Garmin smartwatches and cycling computers to receive voice-activated biometric data through the Meta AI app from the Garmin Connect IQ Store.

Key features include voice-activated real-time stats, visual LED status updates for performance metrics, and automatic video capture based on performance milestones. The integration also offers post-workout highlights and the ability to share activity data with performance metric overlays on social media platforms.

The service is currently available only in the US, with planned expansion to other regions.

Garmin (NYSE:GRMN) has announced a landmark research collaboration with King's College London as the exclusive smartwatch provider for the EMBRACE program. The research initiative will collect biometric data from up to 40,000 adult participants, making it Garmin's largest research institution partnership to date.

The EMBRACE program will utilize Garmin smartwatches to monitor physiological metrics including heart rate, sleep patterns, and Body Battery™ data. The collected data will support AI-based clinical studies focused on conditions like gestational diabetes, pregnancy hypertension, and perinatal depression. The research aims to develop machine learning models to identify digital biomarkers for personalized interventions in maternal and baby health care.